As discussed earlier, tumor-infiltrating Tregs highly upregulate expression of various immune checkpoint molecules (CTLA-4, PD-1, LAG-3, TIM-3, GITR), making them viable targets for ICI. The gene discussed is CTLA4; the disease is neoplasm.